<DOC>
	<DOC>NCT02586818</DOC>
	<brief_summary>This study is designed to evaluate and verify the clinical accuracy of the InRhythm PT/INR system; a point-of-care, whole blood PT/INR measurement with a reference plasma based PT/INR using a laboratory reference instrument and reagent (Sysmex/Innovin) calibrated to the WHO rTF09 reference standard.</brief_summary>
	<brief_title>Clinical Performance of InRhythm PT/INR System in a Professional Use Setting</brief_title>
	<detailed_description>The study will be performed at a minimum of three (3) different clinical sites where patients' VKA therapy is managed and routine PT/INR monitoring is performed.</detailed_description>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>The subjects must be &gt; 18 years of age. The subjects must be willing and competent to sign an informed consent. The subjects must be able to attend the clinic for one visit to donate one FS blood sample and one venous blood draw of approximately 10 cc. Additional Inclusion Criteria Therapeutic Group The subject must require oral VKA anticoagulant therapy. The patient must have been anticoagulated for at least three months prior to enrollment. The subject is unable to donate fingerstick and venous blood samples. The subject has a history of clinically significant bleeding associated with incising the finger and/or the venipuncture. The subject is enrolled in any other study that involves an investigational drug and/or device. Additional Exclusion Criteria Normal Group Subjects receiving any form of anticoagulation drugs such as Aspirin or Clopidogrel.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>